Biomarkers, methods, and compositions for treating autoimmune disease including systemic lupus erythematous (sle)
US-2024262907-A1 · Aug 8, 2024 · US
This page is not indexed by search engines while we improve data quality.
Xencor Inc — Physics
Xencor Inc holds 11 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Xencor Inc |
| Technology | Physics |
| Patents in slice | 11 |
| Recent patents in slice | 1 |
| First year | 2015 |
| Last year | 2024 |
Representative patents
Notable publications linking Xencor Inc to Physics.
Biomarkers, methods, and compositions for treating autoimmune disease including systemic lupus erythematous (sle)
US-2024262907-A1 · Aug 8, 2024 · US
Biomarkers, methods, and compositions for treating autoimmune disease including systemic lupus erythematous (sle)
US-2024262907-A1 · Aug 8, 2024 · US
Biomarkers, methods, and compositions for treating autoimmune disease including systemic lupus erythematous (sle)
US-2024262907-A1 · Aug 8, 2024 · US
Biomarkers, methods, and compositions for treating autoimmune disease including systemic lupus erythematous (sle)
US-2024262907-A1 · Aug 8, 2024 · US
Recent filings
Latest patents from Xencor Inc in Physics.
Biomarkers, methods, and compositions for treating autoimmune disease including systemic lupus erythematous (sle)
US-2024262907-A1 · Aug 8, 2024 · US
Biomarkers, methods, and compositions for treating autoimmune disease including systemic lupus erythematous (sle)
US-2024262907-A1 · Aug 8, 2024 · US
Biomarkers, methods, and compositions for treating autoimmune disease including systemic lupus erythematous (sle)
US-2024262907-A1 · Aug 8, 2024 · US
Biomarkers, methods, and compositions for treating autoimmune disease including systemic lupus erythematous (sle)
US-2024262907-A1 · Aug 8, 2024 · US
Biomarkers, methods, and compositions for treating autoimmune disease including systemic lupus erythematous (sle)
US-2024262907-A1 · Aug 8, 2024 · US
Related pages
Navigate to parent entity pages.